Found 15 matching trials
Influenza Antiviral DAS181-F03 PHASE1 Influenza (flu) is a common respiratory infection and often causes severe i...
Show More Location
Johns Hopkins Hospital - Medicine - Infectious Diseases
Learn More & Join Trial
Single Dose Escalating Study of DAS181 in Adults PHASE1 This study will evaluate the safety, tolerability, and systemic exposure of...
Show More Location
Comprehensive Phase One
Learn More & Join Trial
A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis PHASE1 The primary objective is to evaluate whether DAS181 is safe in subjects wit...
Show More Location
NIH Clinical Center
Learn More & Join Trial
Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza PHASE2 This protocol will seek to enroll 372 adult otherwise healthy subjects pres...
Show More Learn More & Join Trial
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study PHASE3 This study will seek to enroll immunocompromised patients with Lower Tract ...
Show More Location
City of Hope cancer Center
Learn More & Join Trial
DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19) PHASE2 This is a Phase IIb study consisting of two cohorts to evaluate efficacy, s...
Show More Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
DAS181 for Severe COVID-19: Compassionate Use NA The objective of the study is to investigate the safety and potential effic...
Show More Location
Renmin Hospital of Wuhan University
Learn More & Join Trial
Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza PHASE2 This protocol will seek to enroll adult otherwise healthy subjects presenti...
Show More Location
Multiple Locations
Learn More & Join Trial
DAS181 Single Dose Escalation Study in Healthy Adults PHASE1 This study will evaluate the safety, tolerability, and systemic exposure of...
Show More Location
Quintiles Phase One Services
Learn More & Join Trial
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen PHASE2 This protocol will seek to enroll immunocompromised patients who are on sup...
Show More Location
Mayo Clinic-Arizona
Learn More & Join Trial